登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603717 证券简称：天域生物公告编号：2025-122 天域生物科技股份有限公司 关于2025年度为合作养殖农户提供担保预计的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 担保对象及基本情况 （一）担保的基本情况 公司分别于2025年01月06日、01月22日召开第四届董事会第三十五次会议和2025年第一次临时股东大 会，会议审议通过了《关于2025年度为合作养殖农户提供担保预计的议案》，同意公司及下属子公司 2025年度预计为养殖农户提供金额不超过人民币5,000.00万元的担保，担保期限自股东大会审议通过之 日起一年内有效，有效期内担保额度可滚动使用。具体内容详见公司于2025年01月07日、01月23日在上 海证券交易所官方网站及指定信息披露媒体上发布的《关于2025年度为合作养殖农户提供担保预计的公 告》、《2025年第一次临时股东大会决议公告》（公告编号：2025-004、2025-010）。 二、被担保人基本情况 （一） ...

证券代码：603717 证券简称：天域生物 公告编号：2025-122 天域生物科技股份有限公司 关于 2025 年度为合作养殖农户提供担保预计的 进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 担保对象及基本情况 为满足优质养殖农户开展合作养殖经营性资金需要，近日公司与湖北枝江农 村商业银行股份有限公司（以下简称"枝江农商行"）签署了《最高额保证合同》， 为养殖农户覃新利与枝江农商行连续签订的借款合同下所形成的债务提供连带 责任保证担保，担保债权最高额为人民币 490.00 万元，担保债权发生期间为 2025 年 12 月 29 日至 2028 年 12 月 29 日，担保期间自主合同项下的借款期限届满或 借款展期后届满之次日起三年。 本担保事项下养殖农户覃新利通过公司担保获得的贷款资金专款专用，专项 用于支付公司控股子公司保证金。 （二）内部决策程序 公司分别于 2025 年 01 月 06 日、01 月 22 日召开第四届董事会第三十五次 会议和 2025 年第一次临时股东大会，会议审议通过了《 ...

Group 1 - The aquaculture sector increased by 1.58% on December 29, with Jingji Zhino leading the gains [1] - The Shanghai Composite Index closed at 3965.28, up 0.04%, while the Shenzhen Component Index closed at 13537.1, down 0.49% [1] - Key stocks in the aquaculture sector showed varied performance, with Jingji Zhino rising by 10.01% to a closing price of 16.27 [1] Group 2 - The main funds in the aquaculture sector saw a net inflow of 90.42 million yuan, while retail funds had a net inflow of 10.91 million yuan [2] - Major stocks like Muyuan Foods and Wen's Foodstuffs experienced significant net outflows from retail investors [3] - Jingji Zhino had a net inflow of 67.42 million yuan from main funds, indicating strong institutional interest [3]

Group 1 - The core viewpoint of the news is that Tianyu Biological has experienced a decline in stock price and financial performance, indicating potential challenges for the company in the market [1][2]. - As of December 23, Tianyu Biological's stock price was 7.67 yuan per share, with a market capitalization of 2.225 billion yuan. The stock has decreased by 4.72% year-to-date and 15.44% over the past 60 days [1]. - The company has seen a net inflow of main funds amounting to 305,600 yuan, with significant buying and selling activity on the stock [1]. Group 2 - Tianyu Biological operates in the agriculture, forestry, animal husbandry, and fishery sector, specifically in pig farming, and is involved in various related concepts such as characteristic towns and PPP concepts [2]. - For the period from January to September 2025, the company reported a revenue of 536 million yuan, a year-on-year decrease of 14.23%, and a net profit attributable to shareholders of -1.61 million yuan, a decrease of 125.22% [2]. - The company has not distributed any dividends in the past three years, with a total payout of 34.54 million yuan since its A-share listing [3].

证券日报网讯 12月19日，天域生物发布公告称，公司第五届董事会第五次会议审议通过《关于2026年 度为合作养殖农户提供担保预计的议案》等多项议案。 （文章来源：证券日报） ...

Group 1 - The company announced that it will provide guarantees to cooperative farming households for the year 2026, with a total amount not exceeding RMB 50 million [2] - The guarantee is aimed at promoting long-term cooperation between the company's subsidiaries and farming households, while ensuring risk assessment and asset safety [2] - The guarantee will be effective from the date of approval at the first extraordinary shareholders' meeting in 2026 until the annual shareholders' meeting in 2026 [2]

Core Viewpoint - Tianyu Bio announced the termination of the "Tianchang City Longgang Red Cultural Tourism Scenic Area Project" to improve the efficiency of raised fund usage, reallocating the remaining funds to supplement working capital [2] Group 1: Project Details - The adjusted investment amount for the project is 275.71 million yuan [2] - As of November 30, 2025, the company has invested a total of 216.48 million yuan, achieving a progress rate of 78.52% [2] - The remaining unused raised funds amount to 59.68 million yuan, which includes cash management income and net bank interest received after deducting fees [2] Group 2: Corporate Governance - The decision to terminate the project was approved by the company's fifth board of directors in its fifth meeting [2] - The matter will be submitted for review at the company's first extraordinary shareholders' meeting in 2026 [2]

证券日报网讯12月19日晚间，天域生物（603717）发布公告称，公司将于2026年1月5日召开2026年第一 次临时股东会。 ...

Company Overview - Tianyu Biological (SH 603717) announced on December 19 that its fifth board meeting was held to discuss the termination of fundraising investment projects and the use of remaining funds for permanent working capital [1] Financial Performance - For the year 2024, Tianyu Biological's revenue composition is as follows: pig farming accounts for 72.29%, landscape ecological engineering for 19.78%, red yeast product manufacturing for 3.89%, photovoltaic new energy for 3.17%, and other businesses for 0.87% [1] Market Position - As of the report, Tianyu Biological has a market capitalization of 2.3 billion yuan [1]

关于公司 2026 年度日常关联交易预计的公告 证券代码：603717 证券简称：天域生物 公告编号：2025-119 天域生物科技股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 1 本次年度日常关联交易预计事项尚需提交公司 2026 年第一次临时股东会 审议。 本次日常关联交易符合公司及下属子公司日常经营的需要，有助于公司 业务发展，提升公司市场竞争力。关联交易遵循公平合理的定价原则， 不存在损害公司及全体股东特别是中小股东利益的情形。公司对关联方 不会形成依赖，也不会影响公司的独立性。 公司于 2025 年 12 月 19 日召开了第五届董事会第五次会议，审议通过了 《关于公司 2026 年度日常关联交易预计的议案》，关联董事罗卫国先生已回避 表决，其余 6 名非关联董事一致同意该议案。本次关联交易事项将提交公司 2026 年第一次临时股东会审议，关联股东将在股东会上对该事项回避表决。 （二）2025 年度日常关联交易的预计和执行情况 重要内容提示： 一、日常关联交易基本情况 （一）日常关联交易履行的审议程序 ...